The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Association of Disorders in Mineral Metabolism with Progression of Chronic Kidney Disease
Open accessAbstract
Abnormalities of mineral metabolism are associated with increased mortality in patients with ESRD, but their effects in predialysis chronic kidney disease (CKD) are less well characterized. In this study, the associations between levels of serum phosphorus, calcium, and calcium-phosphorus product and progression of CKD were examined. Historical data were collected on 985 male US veterans (age 67.4 +/- 10.9; 23.9% black) with CKD stages 1 through 5. Unadjusted and multivariable-adjusted relative risks for progressive CKD (defined as the composite of ESRD or doubling of serum creatinine) were calculated for categories of serum phosphorus, calcium, and calcium-phosphorus product using Cox proportional hazards models. Higher phosphorus was associated with a higher risk for the composite end point (adjusted hazard ratio [HR] [95% confidence interval (CI)] for phosphorus levels 3.3 to 3.8, 3.81 to 4.3, and >4.3 versus <3.3 mg/dl 0.83 [0.54 to 1.27], 1.24 [0.82 to 1.88], and 1.60 [1.06 to 2.41]; P = 0.001 for trend). A 1-mg/dl higher phosphorus level was associated with an adjusted HR (95% CI) of 1.29 (1.12 to 1.48; P < 0.001). Higher calcium-phosphorus product also was associated with higher risk for progressive CKD (adjusted HR [95% CI] for calcium-phosphorus products 30 to 35, 36 to 40, and >40 versus <30 mg2/dl2 0.58 [0.36 to 0.94], 0.87 [0.57 to 1.34], and 1.37 [0.91 to 2.07]; P = 0.002 for trend). A 10-mg2/dl2 higher calcium-phosphorus product was associated with an adjusted HR (95% CI) of 1.29 (1.11 to 1.51; P = 0.001). Lower serum calcium showed a trend toward higher risk for progressive CKD but without statistical significance. Higher serum phosphorus and higher calcium-phosphorus product are associated with progression of CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Block, G. A., Klassen, P. S., Lazarus, J. M., Ofsthun, N., Lowrie, E. G., & Chertow, G. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133041.27682.a2 · Cited by 2,687
London, G. M. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg414 · Cited by 1,859
Goodpasture syndrome during the course of a Schönlein-Henoch purpura
Carreras, L., Poveda, R., Bas, J., Mestre, M., Rama, I., & Carrera, M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32799 · Cited by 1,474
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
Chertow, G. M., Burke, S. K., Raggi, P., & for the Treat to Goal Working Group (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00434.x · Cited by 1,462
Phosphate Regulation of Vascular Smooth Muscle Cell Calcification
Jono, S., McKee, M. D., Murry, C. E., Shioi, A., Nishizawa, Y., Mori, K., Morii, H., & Giachelli, C. M. (2000) · Circulation Research · doi:10.1161/01.res.87.7.e10 · Cited by 1,427
Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease
Kestenbaum, B., Sampson, J. N., Rudser, K. D., Patterson, D. J., Seliger, S. L., Young, B., Sherrard, D. J., & Andress, D. L. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070602 · Cited by 1,226
Interpretation of Serum Calcium in Patients with Abnormal Serum Proteins
Payne, R. B., Little, A. J., Williams, R. B., & Milner, J. R. (1973) · BMJ · doi:10.1136/bmj.4.5893.643 · Cited by 945
Reynolds, J. L., Joannides, A. J., Skepper, J. N., McNair, R., Schurgers, L. J., Proudfoot, D., Jahnen-Dechent, W., Weissberg, P. L., & Shanahan, C. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000141960.01035.28 · Cited by 911
Pedrini, M. T., Levey, A. S., Lau, J., Chalmers*, T. C., & Wang, P. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-7-199604010-00002 · Cited by 496
Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells
Chen, N. X., O'Neill, K. D., Duan, D., & Moe, S. M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00625.x · Cited by 335
Preservation of Function in Experimental Renal Disease by Dietary Restriction of Phosphate
Ibels, L. S., Alfrey, A. C., Haut, L., & Huffer, W. E. (1978) · New England Journal of Medicine · doi:10.1056/nejm197801192980302 · Cited by 296
Effects of dietary protein and phosphorus restriction on the progression of early renal failure
Maschio, G., Oldrizzi, L., Tessitore, N., D'Angelo, A., Valvo, E., Lupo, A., Loschiavo, C., Fabris, A., Gammaro, L., Rugiu, C., et al. (1982) · Kidney International · doi:10.1038/ki.1982.184 · Cited by 229
Cardiovascular calcification in patients with end-stage renal disease: A century-old phenomenon
Qunibi, W. Y., Nolan, C. A., & Ayus, J. C. (2002) · Kidney International · doi:10.1046/j.1523-1755.62.s82.15.x · Cited by 141
Relationship of Phosphorus and Calcium-Phosphorus Product With Mortality in CKD
Menon, V., Greene, T., Pereira, A. A., Wang, X., Beck, G. J., Kusek, J. W., Collins, A. J., Levey, A. S., & Sarnak, M. J. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.05.025 · Cited by 126
Insights into the mechanism of vascular calcification
Boström, K. I. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01718-0 · Cited by 112
Calcium Receptor and Regulation of Parathyroid Hormone Secretion
Brown, E. M. (2000) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1026570518919 · Cited by 84
Trends in Molecular Medicine: Molecular determinants of arterial calcification
Schinke, T., McKee, M. D., Kiviranta, R., et al. (1998) · Annals of Medicine · doi:10.3109/07853899709002601 · Cited by 27
Cited by
A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure
Tangri, N. (2011) · JAMA · doi:10.1001/jama.2011.451 · Cited by 1,348
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney Disease
Bolignano, D., Lacquaniti, A., Coppolino, G., Donato, V., Campo, S., Fazio, M. R., Nicocia, G., & Buemi, M. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03530708 · Cited by 561
Understanding Sources of Dietary Phosphorus in the Treatment of Patients with Chronic Kidney Disease
Kalantar-Zadeh, K., Gutekunst, L., Mehrotra, R., Kovesdy, C. P., Bross, R., Shinaberger, C. S., Noori, N., Hirschberg, R., Benner, D., Nissenson, A. R., et al. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06080809 · Cited by 510
Self-citationFGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis
Kendrick, J., Cheung, A. K., Kaufman, J. S., Greene, T., Roberts, W. L., Smits, G., & Chonchol, M. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121224 · Cited by 448
Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder
Fukagawa, M., Yokoyama, K., Koiwa, F., Taniguchi, M., Shoji, T., Kazama, J. J., Komaba, H., Ando, R., Kakuta, T., Fujii, H., et al. (2013) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12058 · Cited by 402
Metadata
- Authors
- Schwarz, S., Trivedi, B. K., Kalantar-Zadeh, K., & Kovesdy, C. P.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2006-07
- Volume
- 1
- Issue
- 4
- Pages
- 825-831
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2120619511
- Cited by
- 263
- References
- 19
- FWCI
- 6.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.